Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 4009 - 4016 of 12018 results
OTC Monograph Reform: Key Takeaways and What Industry Can Expect
June 10, 2020| Blog| Viewpoint
Phase 1 Construction Guidelines: Guidance for Real Estate Developers in New York City
June 10, 2020| Blog| Viewpoint
Cantwell-Cassidy Exposure Notification Privacy Act – A Bipartisan Bill on Disease Contact Tracing
June 9, 2020| Blog| Viewpoint
SEC Whistleblower Complaints Swell to a Flood: How to Find the High Ground of Sound Compliance
June 9, 2020| Alert| Viewpoint
Video Blog Series: Is Your Company Using Bots? All You Need to Know about the B.O.T. Act in 1 Minute
June 8, 2020| Blog| Viewpoint
INSIGHT: Minimizing Risks in Down-Round Financing During COVID-19
June 8, 2020| News
New York Forward Phase 2: Guidance for Commercial Landlords and Office Tenants in New York City
June 8, 2020| Blog| Viewpoint
Video Blog Series: Is Your Company Using or Selling Biometric Technology? BIPA Explained in 2 Minutes
June 5, 2020| Blog| Viewpoint
News & Press Releases
Mintz advised the underwriters in connection with a $230 million public offering by Cogent Biosciences, Inc. of 25,555,556 shares of common stock, which includes 3,333,333 shares issued pursuant to the exercise in full by the underwriters of their option to purchase additional shares of common stock, offered at a public offering price of $9.00 per share. The aggregate gross proceeds to Cogent from this offering were approximately $230 million, including proceeds from the exercise in full by the underwriters of the option to purchase additional shares, before deducting underwriting discounts and commissions and other offering expenses.
Mintz advised the underwriters in connection with a $200 million public offering by Soleno Therapeutics, Inc. of 2,352,941 shares of its common stock at a price to the public of $85.00 per share. The gross proceeds to Soleno from the offering were approximately $200 million before deducting underwriting discounts and commissions and other offering expenses. In addition, Soleno granted the underwriters a 30-day option to purchase up to an additional 352,941 shares of its common stock at the public offering price.
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Events
The Evolving Global Digital Infrastructure: Data Centers, AI, and the Next Wave of Connectivity
New York, NY
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|